Lucas Altepost, vice president of sales and marketing at the firm, said a patented extraction process enabled it to remove omega-3s from fresh salmon rather than the fish meal that is the source of most omega-3 ingredients. This meant extracting the virgin oil within 24 hours of the fish being killed.
Its new facility is set for an official launch by Norwegian government officials in August. Clinical trials are under way and promising results have been shown for the ingredients’ ability to benefit LDL cholesterol levels.
Altepost said, “The results have been very promising in lowering LDL cholesterol compared to other fish oils. The trials are ongoing. We are not making any claims about it yet but the indications are good.”
The company has begun discussions with potential clients in the US, Europe and Asia, with functional foods and food supplements.
Sjur Jenssen, CEO of Hofseth Biocare, said in a statement: “The oil is very stable and all of the natural constituents are preserved, so the oil has a natural pink salmon colour. While the industry is focused on the specification, we are focused on human clinical trials that have shown activity far beyond anything we’ve seen in the marketplace.”
Source: Hofseth Biocare
© FoodBev Media Ltd 2024